Oxurion Postpones Annual Shareholders Meeting

Oxurion NV, a pharmaceutical outsourcing company based in Leuven, Belgium, announced the postponement of its Annual Shareholders Meeting. Originally scheduled for an earlier date, the meeting will now take place on Monday, June 1st, 2026. The delay is attributed to the incomplete finalization of the company's annual accounts due to administrative reasons.

This postponement highlights the importance of thorough financial preparation for public companies. Oxurion, traded on Euronext Brussels under the symbol OXUR, focuses on acquiring majority stakes in European pharmaceutical subcontractors, aiming to create an integrated group to serve healthcare players.

The company also addresses risks associated with planned investments in digital assets, emphasizing potential volatility, regulatory uncertainty, and cybersecurity threats.